Austria (AT)

WHO 2022 classification of penile and scrotal cancers: updates and evolution (2022) Menon S, Moch H, Berney DM, Cree IA, Srigley JR, Tsuzuki T, Comperat E, et al. Journal article ASO Visual Abstract: Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome, and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer (HGSOC). A Multicenter, Retrospective Study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium (2022) Glajzer J, Castillo-Tong DC, Richter R, Vergote I, Kulbe H, Vanderstichele A, Ruscito I, et al. Journal article, Editorial Retinal regions shape human and murine Muller cell proteome profile and functionality (2022) Kaplan L, Drexler C, Pfaller AM, Brenna S, Wunderlich KA, Dimitracopoulos A, Merl-Pham J, et al. Journal article Mixed Methods (2022) Hagenauer G, Gläser-Zikuda M Book chapter / Article in edited volumes Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms Using 68Ga-Pentixafor PET (2022) Buck AK, Haug A, Dreher N, Lambertini A, Higuchi T, Lapa C, Weich A, et al. Journal article I WISH I MAY, I WISH I MIGHT FEEL THE AGE I WISH TONIGHT (2022) Bellingtier J, Rupprecht F, Neupert S, Lang F Conference contribution Cardiac screening prior to return to play after SARS-CoV-2 infection: focus on the child and adolescent athlete: A Clinical Consensus Statement of the Task Force for Childhood Health of the European Association of Preventive Cardiology (2022) D'Ascenzi F, Castelletti S, Adami PE, Cavarretta E, Sanz-De La Garza M, Maestrini V, Biffi A, et al. Journal article LOMUSTINE/TEMOZOLOMIDE CHEMOTHERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED IDHWT GLIOBLASTOMA ACCORDING TO CETEG/NOA-09: REAL-WORLD EXPERIENCE IN A MULTICENTER COHORT (2022) Weller J, Zeyen T, Schlegel U, Lazaridis L, Werner JM, Onken J, Zeiner P, et al. Conference contribution Thrombospondin-2 and LDH: potential predictive biomarkers for the treatment of metastatic renal cell carcinoma with everolimus after one VEGF-targeted therapy (MARC-2 study) (2022) Zeuschner P, Hoelters S, Stoeckle M, Seliger B, Mueller A, Bachmann HS, Gruenwald V, et al. Conference contribution Multicentric validation of a comprehensive geriatric assessment to predict functional outcome and mortality following urooncological operations (2022) Fiebig C, Kahlmeyer A, Bannert H, Taubert H, Wach S, Koneval L, Graf S, et al. Conference contribution